Provided by Tiger Trade Technology Pte. Ltd.

Evolus Inc.

8.78
+0.39004.65%
Post-market: 8.780.00000.00%16:15 EDT
Volume:1.32M
Turnover:11.44M
Market Cap:578.20M
PE:-16.67
High:8.82
Open:8.39
Low:8.26
Close:8.39
52wk High:8.82
52wk Low:3.86
Shares:65.85M
Float Shares:51.01M
Volume Ratio:1.87
T/O Rate:2.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5267
EPS(LYR):-0.8010
ROE:-18729.61%
ROA:-5.40%
PB:-18.71
PE(LYR):-10.96

Loading ...

Evolus Inc Expected to Post a Loss of 3 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Evolus to Report Second-quarter Results After Markets Close, Host Conference Call

Reuters
·
Jul 22

Evolus Reports 115,000 RSU Inducement Grants to 38 New Hires Under 2023 Plan

Reuters
·
Jul 11

Evolus Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 11

Analysts’ Top Healthcare Picks: Evolus (EOLS), Annovis Bio (ANVS)

TIPRANKS
·
Jul 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)

TIPRANKS
·
Jul 08

Evolus partners with IBSA to develop and market Profhilo in the U.S.

TIPRANKS
·
Jul 08

Evolus Partners with IBSA to License, Distribute Profhilo in US

Reuters
·
Jul 08

Evolus - Agreement not Expected to Impact 2026 or 2028 Financial Targets

THOMSON REUTERS
·
Jul 08

Evolus - Under Terms, Co to Lead U.S. Regulatory Approval and Commercialization of Profhilo

THOMSON REUTERS
·
Jul 08

Evolus Announces Partnership with Ibsa to Develop and Commercialize Market-leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality

THOMSON REUTERS
·
Jul 08

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Evolus (EOLS)

TIPRANKS
·
Jul 02

Evolus Price Target Maintained With a $13.00/Share by BTIG

Dow Jones
·
Jun 17

Evolus shareholders elect Brady Stewart, Vikram Malik as Class II directors

Reuters
·
Jun 13

Evolus (EOLS) Receives a Buy from Mizuho Securities

TIPRANKS
·
Jun 09

Evolus files $250M mixed securities shelf

TIPRANKS
·
Jun 06

Evolus - May Offer up to $250 Mln of Securities - SEC Filing

THOMSON REUTERS
·
Jun 06

Evolus management joins Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 19

3 High-Growth Insider-Owned Companies With Earnings Surging Up To 80%

Simply Wall St.
·
May 15

Evolus Plans to Launch Estyme Collection in Europe

MT Newswires Live
·
May 11